AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP

Nucleic Acids Research

Volumn 36, Issue 3, 2008, Pages 1009-1016

  Hartl, Maximilian J ^a   Kretzschmar, Benedikt ^b   Frohn, Anne ^a,c   Nowrouzi, Ali ^a   Rethwilm, Axel ^b   Wöhrl, Birgitta M ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; GLUTAMIC ACID; ISOLEUCINE; LYSINE; MUTANT PROTEIN; OLIGODEOXYNUCLEOTIDE; POLYADENYLIC ACID; RNA DIRECTED DNA POLYMERASE; SERINE; THREONINE; ZIDOVUDINE; ZIDOVUDINE 5' PHOSPHATE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA DNA HYBRIDIZATION; DNA RNA HYBRIDIZATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPUMA VIRUS;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; DIDEOXYNUCLEOTIDES; DNA; DRUG RESISTANCE, VIRAL; ESCHERICHIA COLI; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; RNA; RNA-DIRECTED DNA POLYMERASE; SEQUENCE ALIGNMENT; SPUMAVIRUS; THYMINE NUCLEOTIDES; ZIDOVUDINE;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; MACAQUE SIMIAN FOAMY VIRUS; SIMIAN FOAMY VIRUS;

EID: 39449121912     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm1087     Document Type: Article

References (28)

1. Rethwilm,A. (2003) The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol., 277, 1-26.
2. Linial,M. (2007) Foamy viruses. In Knipe,D.M. and Howley,P.M. (eds), Fields Virology, Vol. 2, Lippincott Williams & Wilkins, Philadelphia, pp. 2245-2262.
3. Pfrepper,K.I., Rackwitz,H.R., Schnölzer,M., Heid,H., Löchelt,M. and Flügel,R.M. (1998) Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. J. Virol., 72, 7648-7652.
4. Moebes,A., Enssle,J., Bieniasz,P.D., Heinkelein,M., Lindemann,D., Bock,M., McClure,M.O. and Rethwilm,A. (1997) Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol., 71, 7305-7311.
5. Rosenblum,L.L., Patton,G., Grigg,A.R., Frater,A.J., Cain,D., Erlwein,O., Hill,C.L., Clarke,J.R. and McClure,M.O. (2001) Differential susceptibility of retroviruses to nucleoside analogues. Antivir. Chem. Chemother., 12, 91-97.
6. Lee,C.C., Ye,F. and Tarantal,A.F. (2006) Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. Stem Cells Dev., 15, 209-220.
7. Kretzschmar,B., Nowrouzi,A., Hartl,M.J., Gärtner,K., Wiktorowicz,T., Herchenröder,O., Kanzler,S., Rudolph,W., Mergia,A. et al. (2008) AZT-resistant Foamy Virus. Virology, 370, 151-157.
8. Arion,D., Kaushik,N., McCormick,S., Borkow,G. and, Parniak,M.A. (1998) Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry, 37, 15908-15917.
9. Meyer,P.R., Matsuura,S.E., So,A.G. and Scott,W.A. (1998) Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc. Natl Acad. Sci. USA, 95 13471-13476.
10. Meyer,P.R., Matsuura,S.E., Mian,A.M., So,A.G. and Scott,W.A. (1999) A mechanism of AZT resistance: An increase in nucleotide dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol. Cell, 4 35-43.
11. Boyer,P.L., Sarafianos,S.G., Clark,P.K., Arnold,E. and Hughes,S.H. (2006) Why do: HIV-1 and HIV-2 use different pathways to develop AZT resistance? PLoS. Pathog., 2, e10.
12. Jacques,P.S., Wöhrl,B.M., Ottmann,M., Darlix,J.-L. and Le Grice,S.F.J. (1994) Mutating the "primer grip" of p66 HIV-1 reverse transcriptase implicates tryptophan-229 in template-primer utilization. J. Biol. Chem., 269, 26472-26478.
13. Werner,S. and Wöhrl,B.M. (1999) Soluble Rous Sarcoma Virus reverse transcriptases α, αβ and β purified from insect cells are processive DNA polymerases that lack an RNase H 3′ > 5′ directed processing activity. J. Biol. Chem., 274, 26329-26336.
14. Krebs,R., Immendörfer,U., Thrall,S., Wöhrl,B.M. and Goody,R.S. (1997) Single-step kinetics of HIV-reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3TC. Biochemistry, 36, 10292-10300.
15. Dharmasena,S., Pongracz,Z., Arnold,E., Sarafianos,S.G. and Parniak,M.A. (2007) 3′-Azido-3′-deoxythymidine-(5′)-tetraphospho- (5′)-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase. Biochemistry, 46, 828-836.
16. Carroll,S.S., Geib,J., Olsen,D.B., Stahlhut,M., Shafer,J.A. and Kuo,L.C. (1994) Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate. Biochemistry, 33, 2113-2120.
17. Lacey,S.F., Reardon,J.E., Furfine,E.S., Kunkel,T.A., Bebenek,K., Eckert,K.A., Kemp,S.D. and Larder,B.A. (1992) Biochemical studies on the reverse transcriptase and RNase H activities from human immunodeficiency virus strains resistant to 3′-azido-3′-deoxythymidine. J. Biol. Chem., 267, 15789-15794.
18. Kerr,S.G. and Anderson,K.S. (1997) RNA dependent DNA replication fidelity of HIV-1 reverse transcriptase: Evidence of discrimination between DNA and RNA substrates. Biochemistry, 36, 14056-14063.
19. Larder,B.A. and Kemp,S.D. (1989) Multiple mutations in HIV-1 reverse transcriptase confer high- level resistance to zidovudine (AZT). Science, 246, 1155-1158.
20. Larder,B.A., Kellam,P. and Kemp,S.D. (1991) Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS, 5, 137-144.
21. Meyer,P.R., Matsuura,S.E., Schinazi,R.F., So,A.G. and Scott,W.A. (2000) Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2′-deoxynucleoside triphosphates. Antimicrob. Agents Chemother., 44, 3465-3472.
22. Boyer,P.L., Sarafianos,S.G., Arnold,E. and Hughes,S.H. (2001) Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J. Virol., 75, 4832-4842.
23. Boyer,P.L., Sarafianos,S.G., Arnold,E. and Hughes,S.H. (2002) The M184V mutation reduces the selective excision of zidovudine 5′-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1. J. Virol., 76, 3248-3256.
24. Boyer,P.L., Sarafianos,S.G., Arnold,E. and Hughes,S.H. (2002) Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision. J. Virol., 76, 9143-9151.
25. Sarafianos,S.G., Clark,A.D.Jr, Das,K., Tuske,S., Birktoft,J.J., Ilankumaran,P., Ramesha,A.R., Sayer,J.M., Jerina,D.M. et al. (2002) Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J., 21, 6614-6624.
26. Smith,A.J., Meyer,P.R., Asthana,D., Ashman,M.R. and Scott,W.A. (2005) Intracellular substrates for the primer-unblocking reaction by human immunodeficiency virus type 1 reverse transcriptase: Detection and quantitation in extracts from quiescent and activated-lymphocyte subpopulations. Antimicrob. Agents Chemother., 49, 1761-1769.
27. Vogt,V.M. (1997) Retroviral virions and genomes. In Coffin,J., Hughes,S.H. and Varmus,H. (eds), Retroviruses, Cold Spring Harbor Laboratory Press, New York, pp. 27-69.
28. Huang,X. and Miller,W. (1991) A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math, 12, 337-357.